Terms: = Leukemia AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Prognosis
267 results:
1. [Clinical Characteristics of CD4
He HS; Wei YF; Ji XY; Xu YH; Yang YQ; Jin XK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):588-594. PubMed ID: 38660871
[TBL] [Abstract] [Full Text] [Related]
2. Advancements in cancer immunotherapies targeting cd20: from pioneering monoclonal antibodies to chimeric antigen receptor-modified T cells.
Dabkowska A; Domka K; Firczuk M
Front Immunol; 2024; 15():1363102. PubMed ID: 38638442
[TBL] [Abstract] [Full Text] [Related]
3. Splenic B-cell lymphoma/leukemia with prominent nucleoli: A three-case series of the newly named old entity and review of literature.
Rai V; Saha A; Gondha S; Manimaran P; Sawhney J
J Cancer Res Ther; 2024 Jan; 20(1):315-320. PubMed ID: 38554340
[TBL] [Abstract] [Full Text] [Related]
4. [miR-181b-5p promotes cell proliferation and induces apoptosis in human acute myeloid leukemia by targeting PAX9].
Li B; Tao Q; Hu X; Li T; Bao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Dec; 39(12):1074-1082. PubMed ID: 38140866
[TBL] [Abstract] [Full Text] [Related]
5. Importance of Minimal Residual Disease in the Era of Targeted Therapies in Chronic Lymphocytic leukemia.
Al-Sawaf O
Acta Haematol; 2024; 147(1):22-32. PubMed ID: 37903476
[TBL] [Abstract] [Full Text] [Related]
6. Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma.
Yang X; Luo C; Qian J; Huang X; Zhang J; Wang J; Luo C; Qin X; Li B; Chen J
Front Immunol; 2023; 14():1219872. PubMed ID: 37736096
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Characteristics and Diagnosis of Acute Myeloid leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm.
Zhang X; Wu Y; Li C; Shen K; Li R
Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307129
[TBL] [Abstract] [Full Text] [Related]
8. Flow Cytometry of CD5-Positive Hairy Cell leukemia.
Cenariu D; Rus I; Bergthorsson JT; Grewal R; Cenariu M; Greiff V; Tigu AB; Dima D; Selicean C; Petrushev B; Zdrenghea M; Fromm J; Aanei CM; Tomuleasa C
Mol Diagn Ther; 2023 Sep; 27(5):593-599. PubMed ID: 37291380
[TBL] [Abstract] [Full Text] [Related]
9. Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia.
Moles E; Howard CB; Huda P; Karsa M; McCalmont H; Kimpton K; Duly A; Chen Y; Huang Y; Tursky ML; Ma D; Bustamante S; Pickford R; Connerty P; Omari S; Jolly CJ; Joshi S; Shen S; Pimanda JE; Dolnikov A; Cheung LC; Kotecha RS; Norris MD; Haber M; de Bock CE; Somers K; Lock RB; Thurecht KJ; Kavallaris M
Sci Transl Med; 2023 May; 15(696):eabm1262. PubMed ID: 37196067
[TBL] [Abstract] [Full Text] [Related]
10. [Clinical features and prognosis of eight patients with splenic diffuse red pulp small B-cell lymphoma].
Zhang XL; Luo J; Zhang JJ; Chen L; Shen Y; Yi HM; Fan LQ; Mi JQ
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1028-1033. PubMed ID: 36709109
[No Abstract] [Full Text] [Related]
11. Prognostic markers in patients with chronic lymphocytic leukaemia on targeted therapy, chemoimmunotherapy with anti-cd20 monoclonal antibody: a systematic review and meta-analysis of prognostic factors.
Mkhwanazi ZA; Nyambuya TM; Mfusi SA; Nkambule BB
BMC Cancer; 2022 Nov; 22(1):1218. PubMed ID: 36434612
[TBL] [Abstract] [Full Text] [Related]
12. [Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
Zhang M; Wu P; Duan YL; Jin L; Yang J; Huang S; Liu Y; Hu B; Zhai XW; Wang HS; Fu Y; Li F; Yang XM; Liu AS; Qin S; Yuan XJ; Dong YS; Liu W; Zhou JW; Zhang LP; Jia YP; Wang J; Qu LJ; Dai YP; Guan GT; Sun LR; Jiang J; Liu R; Jin RM; Wang ZJ; Wang XG; Zhang BX; Chen KL; Zhuang SQ; Zhang J; Zhou CJ; Gao ZF; Zheng MC; Zhang Y
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1011-1018. PubMed ID: 36207847
[No Abstract] [Full Text] [Related]
13. The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma.
Lind J; Hellinger R; Kudweis P; Moll HP; Gattringer J; Thell K; Edtmayer S; Gruber CW; Stoiber D; Kollmann K
Biomed Pharmacother; 2022 Sep; 153():113486. PubMed ID: 36076504
[TBL] [Abstract] [Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation overcome the poor prognosis of patients with IKZF1plus cd20-a very high-risk subtype in B-cell acute lymphoblastic leukemia.
Tang B; Cai Z; Wang Z; Lin D; He X; Li Q; Liang X; Huang K; Zhou X; Lin R; Xu N; Fan Z; Huang F; Sun J; Liu X; Liu Q; Zhou H
Bone Marrow Transplant; 2022 Dec; 57(12):1751-1757. PubMed ID: 36056210
[TBL] [Abstract] [Full Text] [Related]
15. Predictive role of NKCD56bright cells in monitoring the progression of chronic lymphocytic leukemia during treatment.
Blachnio K; Grygalewicz B; Woroniecka R; Rygier J; Pienkowska-Grela B; Rymkiewicz G; Kawiak J
Folia Histochem Cytobiol; 2022; 60(3):203-214. PubMed ID: 36045602
[TBL] [Abstract] [Full Text] [Related]
16. Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction.
Kulis J; Sędek Ł; Słota Ł; Perkowski B; Szczepański T
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011285
[TBL] [Abstract] [Full Text] [Related]
17. Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis.
Vogiatzi F; Heymann J; Müller K; Winterberg D; Drakul A; Rösner T; Lenk L; Heib M; Gehlert CL; Cario G; Schrappe M; Claviez A; Bornhauser B; Bourquin JP; Bomken S; Adam D; Frielitz FS; Maecker-Kolhoff B; Stanulla M; Valerius T; Peipp M; Kellner C; Schewe DM
Blood Adv; 2022 Aug; 6(16):4847-4858. PubMed ID: 35820018
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of Multiple Vitamins Serum Levels and Disease-Related Factors in Children with Acute leukemia.
Song Z; Li J; Cao J; Zhang L; Zhang Z; Feng S; Zhong D; Yue M; Hu M; Liu R
J Healthc Eng; 2022; 2022():5330563. PubMed ID: 35463661
[TBL] [Abstract] [Full Text] [Related]
19. New Treatment Options for Newly-Diagnosed and Relapsed Chronic Lymphocytic leukemia.
Iskierka-Jażdżewska E; Obracaj A; Urbaniak M; Robak T
Curr Treat Options Oncol; 2022 Jun; 23(6):775-795. PubMed ID: 35357653
[TBL] [Abstract] [Full Text] [Related]
20. Novel Approaches for the Treatment of Patients with Richter's Syndrome.
Iannello A; Deaglio S; Vaisitti T
Curr Treat Options Oncol; 2022 Apr; 23(4):526-542. PubMed ID: 35294723
[TBL] [Abstract] [Full Text] [Related]
[Next]